178 related articles for article (PubMed ID: 29483923)
1. Research Advances in the Correlation between Peroxisome Proliferator-Activated Receptor-
Xu S; Xu X
PPAR Res; 2018; 2018():5289859. PubMed ID: 29483923
[TBL] [Abstract][Full Text] [Related]
2. Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma.
Mössner R; Schulz U; Krüger U; Middel P; Schinner S; Füzesi L; Neumann C; Reich K
J Invest Dermatol; 2002 Sep; 119(3):576-82. PubMed ID: 12230498
[TBL] [Abstract][Full Text] [Related]
3. PPARγ and Its Ligands: Potential Antitumor Agents in the Digestive System.
Shu L; Huang R; Wu S; Chen Z; Sun K; Jiang Y; Cai X
Curr Stem Cell Res Ther; 2016; 11(3):274-81. PubMed ID: 26122910
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome Proliferator-Activated Receptor-γ and Its Ligands in the Treatment of Tumors in the Nervous System.
Shen Y; Lu Y; Yu F; Zhu C; Wang H; Wang J
Curr Stem Cell Res Ther; 2016; 11(3):208-15. PubMed ID: 26216127
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-gamma agonists cause growth arrest and apoptosis in human ovarian carcinoma cell lines.
Yang YC; Tsao YP; Ho TC; Choung IP
Int J Gynecol Cancer; 2007; 17(2):418-25. PubMed ID: 17316361
[TBL] [Abstract][Full Text] [Related]
6. Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer.
Chang TH; Szabo E
Cancer Res; 2000 Feb; 60(4):1129-38. PubMed ID: 10706135
[TBL] [Abstract][Full Text] [Related]
7. Functions of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Gynecologic Disorders.
Ren P; Zhang Y; Huang Y; Yang Y; Jiang M
Clin Med Insights Oncol; 2015; 9():43-9. PubMed ID: 25987855
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation.
Na HK; Surh YJ
Biochem Pharmacol; 2003 Oct; 66(8):1381-91. PubMed ID: 14555212
[TBL] [Abstract][Full Text] [Related]
9. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
Lapillonne H; Konopleva M; Tsao T; Gold D; McQueen T; Sutherland RL; Madden T; Andreeff M
Cancer Res; 2003 Sep; 63(18):5926-39. PubMed ID: 14522919
[TBL] [Abstract][Full Text] [Related]
10. Role of peroxisome proliferator-activated receptor-gamma (PPARgamma) during liver regeneration in rats.
Yamamoto Y; Ono T; Dhar DK; Yamanoi A; Tachibana M; Tanaka T; Nagasue N
J Gastroenterol Hepatol; 2008 Jun; 23(6):930-7. PubMed ID: 18565023
[TBL] [Abstract][Full Text] [Related]
11. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth of pancreatic cancers both in vitro and in vivo.
Itami A; Watanabe G; Shimada Y; Hashimoto Y; Kawamura J; Kato M; Hosotani R; Imamura M
Int J Cancer; 2001 Nov; 94(3):370-6. PubMed ID: 11745416
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human chondrosarcoma cell growth via apoptosis by peroxisome proliferator-activated receptor-gamma.
Nishida K; Furumatsu T; Takada I; Kawai A; Yoshida A; Kunisada T; Inoue H
Br J Cancer; 2002 Apr; 86(8):1303-9. PubMed ID: 11953889
[TBL] [Abstract][Full Text] [Related]
13. Expression of peroxisome proliferator-activated receptor gamma and the growth inhibitory effect of its synthetic ligands in human salivary gland cancer cell lines.
Begum NM; Nakashiro K; Kawamata H; Uchida D; Shintani S; Ikawa Y; Sato M; Hamakawa H
Int J Oncol; 2002 Mar; 20(3):599-605. PubMed ID: 11836575
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor gamma (PPargamma) as a novel target for prostate cancer.
Smith MR; Kantoff PW
Invest New Drugs; 2002 May; 20(2):195-200. PubMed ID: 12099579
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) as a Target for Concurrent Management of Diabetes and Obesity-Related Cancer.
Wang Q; Imam MU; Yida Z; Wang F
Curr Pharm Des; 2017; 23(25):3677-3688. PubMed ID: 28677503
[TBL] [Abstract][Full Text] [Related]
16. Novel expression and function of peroxisome proliferator-activated receptor gamma (PPARgamma) in human neuroblastoma cells.
Han SW; Greene ME; Pitts J; Wada RK; Sidell N
Clin Cancer Res; 2001 Jan; 7(1):98-104. PubMed ID: 11205925
[TBL] [Abstract][Full Text] [Related]
17. Regulation of macrophage gene expression by peroxisome-proliferator-activated receptor gamma: implications for cardiovascular disease.
Tontonoz P; Nagy L
Curr Opin Lipidol; 1999 Dec; 10(6):485-90. PubMed ID: 10680041
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor gamma in human prostate carcinoma.
Nakamura Y; Suzuki T; Sugawara A; Arai Y; Sasano H
Pathol Int; 2009 May; 59(5):288-93. PubMed ID: 19432669
[TBL] [Abstract][Full Text] [Related]
19. Expression of peroxisome proliferator-activated receptor gamma in salivary duct carcinoma: immunohistochemical analysis of 15 cases.
Mukunyadzi P; Ai L; Portilla D; Barnes EL; Fan CY
Mod Pathol; 2003 Dec; 16(12):1218-23. PubMed ID: 14681322
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma.
Eucker J; Sterz J; Krebbel H; Zavrski I; Kaiser M; Zang C; Heider U; Jakob C; Elstner E; Sezer O
Anticancer Drugs; 2006 Aug; 17(7):763-9. PubMed ID: 16926626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
